Molly Czachor joined SPRI in June 2022. Her primary research includes understanding the effect of NGF on bone fracture repair and helping develop transitionally relevant NGF-based therapeutics to accelerate fracture repair. Additionally, she plays a critical role in collecting and analyzing data from the ongoing clinical trials.
In 2022, Molly obtained a degree in Biomedical Engineering from the University of Utah with a minor in chemistry. Throughout undergraduate, she worked in a research lab at the Salt Lake VAMC (Loc-Carrillo Lab) that focused on using bacteriophage and antibiotic combination treatments to treat bacterial infections. Molly completed a senior thesis titled, “Analyzing the efficacy of a 2-bacteriophage vs. 5-bacteriophage phage and antibiotic combination treatment on Staphylococcus aureus static biofilms.”
Molly hopes to continue her education and will be applying to PhD programs in the near future. Outside of work, she enjoys the outdoors through hiking, skiing, and camping. She also loves playing soccer and cheering on her home football team, the Green Bay Packers.